Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Sarcoma 1 Osteosarcoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Chondrosarcoma 1 Cholangiocarcinoma 1

Interventions

Cyclophosphamide 25 Temozolomide 22 Vincristine 18 Irinotecan 18 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 cabozantinib 7 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 regorafenib 5 fludarabine 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Radiotherapy 5 Gemcitabine 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 irinotecan sucrosofate 4 ganitumab 4 fludarabine phosphate 4 Trabectedin 4 Phantoms, Imaging 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Metformin × Sarcoma × Clear all

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡